Literature DB >> 30780065

Are subsyndromal manifestations of attention deficit hyperactivity disorder morbid in children? A systematic qualitative review of the literature with meta-analysis.

Anna-Mariya Kirova1, Caroline Kelberman1, Barbara Storch1, Maura DiSalvo1, K Yvonne Woodworth1, Stephen V Faraone2, Joseph Biederman3.   

Abstract

We conducted a qualitative review (n = 15 manuscripts) and meta-analysis (n = 9 manuscripts) of the extant literature to evaluate the prevalence and morbidity of subthreshold Attention Deficit Hyperactivity Disorder (ADHD). Our qualitative review showed that a sizable minority (mean: 17.7%) of clinically referred and non-referred children met a priori definitions of subthreshold ADHD. Those affected exhibited significantly higher rates of family dysfunction, cognitive impairment, executive dysfunction, interpersonal and school deficits, temperament problems, psychiatric comorbidity, and juvenile delinquency compared to children with no ADHD symptoms. These deficits were highly consistent with those observed in children with full threshold ADHD. These findings indicate that children with subthreshold ADHD symptoms are at significantly greater risk for negative outcomes in a wide range of non-overlapping functional domains worthy of further clinical and scientific consideration.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  ADHD; Diagnosis; Diagnostic criteria; Subthreshold

Mesh:

Year:  2019        PMID: 30780065     DOI: 10.1016/j.psychres.2019.02.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Mortality in individuals with childhood ADHD or subthreshold symptoms - a prospective perinatal risk cohort study over 40 years.

Authors:  Nella Schiavone; Maarit Virta; Sami Leppämäki; Jyrki Launes; Ritva Vanninen; Annamari Tuulio-Henriksson; Ilkka Järvinen; Eliisa Lehto; Katarina Michelsson; Laura Hokkanen
Journal:  BMC Psychiatry       Date:  2022-05-09       Impact factor: 4.144

Review 2.  The Benefits and Limitations of Stimulants in Treating ADHD.

Authors:  David Coghill
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 3.  Cognitive and Behavioural Attention in Children with Low-Moderate and Heavy Doses of Prenatal Alcohol Exposure: a Systematic Review and Meta-analysis.

Authors:  Philippa Pyman; Simonne E Collins; Evelyne Muggli; Renee Testa; Peter J Anderson
Journal:  Neuropsychol Rev       Date:  2021-03-03       Impact factor: 7.444

Review 4.  The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.

Authors:  Stephen V Faraone; Tobias Banaschewski; David Coghill; Yi Zheng; Joseph Biederman; Mark A Bellgrove; Jeffrey H Newcorn; Martin Gignac; Nouf M Al Saud; Iris Manor; Luis Augusto Rohde; Li Yang; Samuele Cortese; Doron Almagor; Mark A Stein; Turki H Albatti; Haya F Aljoudi; Mohammed M J Alqahtani; Philip Asherson; Lukoye Atwoli; Sven Bölte; Jan K Buitelaar; Cleo L Crunelle; David Daley; Søren Dalsgaard; Manfred Döpfner; Stacey Espinet; Michael Fitzgerald; Barbara Franke; Manfred Gerlach; Jan Haavik; Catharina A Hartman; Cynthia M Hartung; Stephen P Hinshaw; Pieter J Hoekstra; Chris Hollis; Scott H Kollins; J J Sandra Kooij; Jonna Kuntsi; Henrik Larsson; Tingyu Li; Jing Liu; Eugene Merzon; Gregory Mattingly; Paulo Mattos; Suzanne McCarthy; Amori Yee Mikami; Brooke S G Molina; Joel T Nigg; Diane Purper-Ouakil; Olayinka O Omigbodun; Guilherme V Polanczyk; Yehuda Pollak; Alison S Poulton; Ravi Philip Rajkumar; Andrew Reding; Andreas Reif; Katya Rubia; Julia Rucklidge; Marcel Romanos; J Antoni Ramos-Quiroga; Arnt Schellekens; Anouk Scheres; Renata Schoeman; Julie B Schweitzer; Henal Shah; Mary V Solanto; Edmund Sonuga-Barke; César Soutullo; Hans-Christoph Steinhausen; James M Swanson; Anita Thapar; Gail Tripp; Geurt van de Glind; Wim van den Brink; Saskia Van der Oord; Andre Venter; Benedetto Vitiello; Susanne Walitza; Yufeng Wang
Journal:  Neurosci Biobehav Rev       Date:  2021-02-04       Impact factor: 9.052

5.  Cognitive Control Deficits in Children With Subthreshold Attention-Deficit/Hyperactivity Disorder.

Authors:  Caiqi Chen; Zhuangyang Li; Xiqin Liu; Yongling Pan; Tingting Wu
Journal:  Front Hum Neurosci       Date:  2022-03-11       Impact factor: 3.169

6.  Gray matter networks associated with attention and working memory deficit in ADHD across adolescence and adulthood.

Authors:  Kuaikuai Duan; Wenhao Jiang; Kelly Rootes-Murdy; Gido H Schoenmacker; Alejandro Arias-Vasquez; Jan K Buitelaar; Martine Hoogman; Jaap Oosterlaan; Pieter J Hoekstra; Dirk J Heslenfeld; Catharina A Hartman; Vince D Calhoun; Jessica A Turner; Jingyu Liu
Journal:  Transl Psychiatry       Date:  2021-03-25       Impact factor: 6.222

7.  Can the Child Behavior Checklist (CBCL) help characterize the types of psychopathologic conditions driving child psychiatry referrals?

Authors:  Joseph Biederman; Maura DiSalvo; Carrie Vaudreuil; Janet Wozniak; Mai Uchida; K Yvonne Woodworth; Allison Green; Stephen V Faraone
Journal:  Scand J Child Adolesc Psychiatr Psychol       Date:  2020-10-31

Review 8.  Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis.

Authors:  Pei-Yin Pan; Ulf Jonsson; Sabriye Selin Şahpazoğlu Çakmak; Alexander Häge; Sarah Hohmann; Hjalmar Nobel Norrman; Jan K Buitelaar; Tobias Banaschewski; Samuele Cortese; David Coghill; Sven Bölte
Journal:  Psychol Med       Date:  2021-10-12       Impact factor: 7.723

9.  Facial emotion recognition impairment predicts social and emotional problems in children with (subthreshold) ADHD.

Authors:  Anouck I Staff; Marjolein Luman; Saskia van der Oord; Catharina E Bergwerff; Barbara J van den Hoofdakker; Jaap Oosterlaan
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-01-07       Impact factor: 5.349

10.  Exploring ADHD Symptoms and Associated Impairment across Development.

Authors:  Ayako Niina; Olga Eyre; Robyn Wootton; Evie Stergiakouli; Anita Thapar; Lucy Riglin
Journal:  J Atten Disord       Date:  2021-06-24       Impact factor: 3.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.